Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 10, 2024

BUY
$151.44 - $200.09 $174,610 - $230,703
1,153 New
1,153 $227,000
Q2 2023

Jul 13, 2023

BUY
$160.94 - $186.23 $191,196 - $221,241
1,188 New
1,188 $204,000
Q3 2022

Nov 02, 2022

BUY
$148.29 - $182.55 $205,826 - $253,379
1,388 New
1,388 $209,000
Q1 2022

Apr 25, 2022

SELL
$181.39 - $234.03 $188,282 - $242,923
-1,038 Closed
0 $0
Q4 2021

Jun 06, 2022

SELL
$193.69 - $247.03 $1.21 Million - $1.54 Million
-6,228 Reduced 85.71%
1,038 $253,000
Q4 2021

Jan 18, 2022

BUY
$193.69 - $247.03 $1.21 Million - $1.54 Million
6,228 Added 600.0%
7,266 $1.77 Million
Q3 2021

Oct 13, 2021

SELL
$189.29 - $209.69 $15,900 - $17,613
-84 Reduced 7.49%
1,038 $202,000
Q2 2021

Jul 14, 2021

BUY
$155.9 - $187.99 $174,919 - $210,924
1,122 New
1,122 $209,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Aries Wealth Management Portfolio

Follow Aries Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aries Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aries Wealth Management with notifications on news.